---
layout: post
title: "Prescription Drug User Fee Act Waivers, Reductions, and Refunds for Fixed-Combinations and Single-Entity Versions of Previously Approved Antiretrovirals Under the President's Emergency Plan for Acquired Immunodeficiency Syndrome Relief; Draft Guidance for Industry; Availability"
date: 2026-02-05 18:56:21 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-16560
original_published: 2023-08-03 00:00:00 +0000
significance: 8.00
---

# Prescription Drug User Fee Act Waivers, Reductions, and Refunds for Fixed-Combinations and Single-Entity Versions of Previously Approved Antiretrovirals Under the President's Emergency Plan for Acquired Immunodeficiency Syndrome Relief; Draft Guidance for Industry; Availability

**Published:** February 05, 2026 18:56 UTC
**Source:** Federal Register
**Original Published:** August 03, 2023 00:00 UTC
**Document Number:** 2023-16560

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "PDUFA Waivers, Reductions, and Refunds for Fixed-Combinations and Single- Entity Versions of Previously Approved Antiretrovirals under PEPFAR." The draft guidance describes circumstances under which an applicant may be eligible for a barrier-to-innovation waiver under the Prescription Drug User Fee Act (PDUFA) for certain new drug applications (NDAs) for single-entity (SE) antiretroviral (ARV) and fixed-combination (FC) ARV drug products for the treatment or prevention of human immunodeficiency virus-one (HIV-1). The draft guidance is also intended to help applicants request a barrier-to-innovation waiver under those circumstances.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/08/03/2023-16560/prescription-drug-user-fee-act-waivers-reductions-and-refunds-for-fixed-combinations-and)
- API: https://www.federalregister.gov/api/v1/documents/2023-16560

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
